![BUPRENORPHINE AND NALOXONE (buprenorphine and naloxone) sublingual tablets CIII 8 mg/2 mg | Mallinckrodt Pharmaceuticals BUPRENORPHINE AND NALOXONE (buprenorphine and naloxone) sublingual tablets CIII 8 mg/2 mg | Mallinckrodt Pharmaceuticals](https://www.mallinckrodt.com/globalassets/images/product-images/addiction-treatment/buprenorphine-and-naloxone/buprenorphine-hcl-and-naloxone-hcl-8mg-2mg-tabs-lg.jpg)
BUPRENORPHINE AND NALOXONE (buprenorphine and naloxone) sublingual tablets CIII 8 mg/2 mg | Mallinckrodt Pharmaceuticals
![These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-05.jpg&id=732664)
These highlights do not include all the information needed to use BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for BUPRENORPHINE and NALOXONE SUBLINGUAL TABLETS. BUPRENORPHINE and NALOXONE
![Increasing Buprenorphine-Naloxone Dose in Response to Recent Opioid Use Appears to Reduce Risk of Relapse - Addiction Technology Transfer Center (ATTC) Network Increasing Buprenorphine-Naloxone Dose in Response to Recent Opioid Use Appears to Reduce Risk of Relapse - Addiction Technology Transfer Center (ATTC) Network](https://attcnetwork.org/wp-content/uploads/2022/03/ASME-April2022-buprenorphine.jpg)
Increasing Buprenorphine-Naloxone Dose in Response to Recent Opioid Use Appears to Reduce Risk of Relapse - Addiction Technology Transfer Center (ATTC) Network
![Zubsolv (Buprenorphine and Naloxone) - Maintenance Treatment for Opioid Dependence - Clinical Trials Arena Zubsolv (Buprenorphine and Naloxone) - Maintenance Treatment for Opioid Dependence - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/1-image-31.jpg)
Zubsolv (Buprenorphine and Naloxone) - Maintenance Treatment for Opioid Dependence - Clinical Trials Arena
![BUPRENORPHINE AND NALOXONE (ORAL/SUBLINGUAL) - - Generic Name , Brand Names, How to use,Side Effects BUPRENORPHINE AND NALOXONE (ORAL/SUBLINGUAL) - - Generic Name , Brand Names, How to use,Side Effects](https://i.ytimg.com/vi/qFsNaf91OUI/maxresdefault.jpg)